8-K Announcements
6Apr 24, 2026·SEC
Apr 24, 2026·SEC
Apr 14, 2026·SEC
The Procter & Gamble Company (PG) fundamental analysis — strengths, weaknesses & financial health based on data analysis
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when PG posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
The Procter & Gamble Company (PG) stock price & volume — 10-year historical chart
The Procter & Gamble Company (PG) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
The Procter & Gamble Company (PG) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 24, 2026 | $1.59vs $1.56+1.9% | $21.2Bvs $20.5B+3.4% |
| Q1 2026 | Jan 22, 2026 | $1.88vs $1.86+1.1% | $22.2Bvs $22.3B-0.4% |
| Q4 2025 | Oct 24, 2025 | $1.99vs $1.90+4.7% | $22.4Bvs $22.2B+0.9% |
| Q3 2025 | Jul 29, 2025 | $1.48vs $1.42+4.2% | $20.9Bvs $20.8B+0.2% |
The Procter & Gamble Company (PG) competitors in Household Cleaning and Paper Goods — business model, growth, and fundamentals comparison
The Procter & Gamble Company (PG) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
The Procter & Gamble Company (PG) annual income statement — 10-year revenue, gross profit & net income history
| Metric | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 65.06B | 66.83B | 67.68B | 70.95B | 76.12B | 80.19B | 82.01B | 84.04B | 84.28B | 86.72B |
Revenue Growth % | -0.37% | 2.73% | 1.27% | 4.83% | 7.28% | 5.35% | 2.27% | 2.48% | 0.29% | 3.33% |
Cost of Goods Sold | 32.64B | 34.43B | 34.77B | 35.25B | 37.11B | 42.16B | 42.76B | 40.85B | 41.16B | 43.07B |
COGS % of Revenue | 50.17% | 51.52% | 51.37% | 49.68% | 48.75% | 52.57% | 52.14% | 48.61% | 48.84% | - |
Gross Profit | 32.42B▲ 0% | 32.4B▼ 0.1% | 32.92B▲ 1.6% | 35.7B▲ 8.5% | 39.01B▲ 9.3% | 38.03B▼ 2.5% | 39.25B▲ 3.2% | 43.19B▲ 10.1% | 43.12B▼ 0.2% | 43.64B▲ 0% |
Gross Margin % | 49.83% | 48.48% | 48.63% | 50.32% | 51.25% | 47.43% | 47.86% | 51.39% | 51.16% | 50.33% |
Gross Profit Growth % | 0.09% | -0.06% | 1.59% | 8.46% | 9.27% | -2.51% | 3.2% | 10.05% | -0.16% | - |
Operating Expenses | 18.65B | 19.04B | 27.43B | 19.99B | 21.02B | 20.22B | 21.11B | 24.65B | 22.67B | 23.49B |
OpEx % of Revenue | 28.67% | 28.48% | 40.53% | 28.18% | 27.62% | 25.21% | 25.74% | 29.33% | 26.9% | - |
Selling, General & Admin | 18.65B | 19.04B | 19.08B | 19.99B | 21.02B | 20.22B | 21.11B | 23.3B | 22.67B | 23.49B |
SG&A % of Revenue | 28.67% | 28.48% | 28.2% | 28.18% | 27.62% | 25.21% | 25.74% | 27.73% | 26.9% | - |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
Other Operating Expenses | 0 | 0 | 8.35B | 0 | 0 | 0 | 0 | 1.34B | 0 | -1000K |
Operating Income | 13.77B▲ 0% | 13.36B▼ 2.9% | 5.49B▼ 58.9% | 15.71B▲ 186.2% | 17.99B▲ 14.5% | 17.81B▼ 1.0% | 18.13B▲ 1.8% | 18.55B▲ 2.3% | 20.45B▲ 10.3% | 20.15B▲ 0% |
Operating Margin % | 21.16% | 19.99% | 8.11% | 22.14% | 23.63% | 22.21% | 22.11% | 22.07% | 24.26% | 23.24% |
Operating Income Growth % | 2.42% | -2.93% | -58.94% | 186.24% | 14.52% | -0.96% | 1.8% | 2.27% | 10.28% | - |
EBITDA | 16.59B | 16.2B | 8.31B | 18.72B | 20.72B | 20.62B | 20.85B | 21.44B | 23.3B | 21.87B |
EBITDA Margin % | 25.49% | 24.24% | 12.28% | 26.38% | 27.22% | 25.71% | 25.42% | 25.51% | 27.64% | 25.22% |
EBITDA Growth % | 0.41% | -2.35% | -48.69% | 125.23% | 10.7% | -0.49% | 1.11% | 2.84% | 8.66% | -4.35% |
D&A (Non-Cash Add-back) | 2.82B | 2.83B | 2.82B | 3.01B | 2.73B | 2.81B | 2.71B | 2.9B | 2.85B | 1.48B |
EBIT | 13.72B | 13.83B | 6.58B | 16.3B | 18.12B | 18.43B | 19.11B | 19.69B | 21.07B | 16.57B |
Net Interest Income | -294M | -259M | -289M | -310M | -457M | -388M | -449M | -452M | -438M | 138M |
Interest Income | 171M | 247M | 220M | 155M | 45M | 51M | 307M | 473M | 469M | 427M |
Interest Expense | 465M | 506M | 509M | 465M | 502M | 439M | 756M | 925M | 907M | -34M |
Other Income/Expense | -509M | -37M | 582M | 128M | -371M | 182M | 219M | 216M | -284M | 812M |
Pretax Income | 13.26B▲ 0% | 13.33B▲ 0.5% | 6.07B▼ 54.5% | 15.83B▲ 160.9% | 17.61B▲ 11.2% | 18B▲ 2.2% | 18.35B▲ 2.0% | 18.76B▲ 2.2% | 20.17B▲ 7.5% | 20.96B▲ 0% |
Pretax Margin % | 20.38% | 19.94% | 8.97% | 22.32% | 23.14% | 22.44% | 22.38% | 22.32% | 23.93% | 24.18% |
Income Tax | 3.06B | 3.46B | 2.1B | 2.73B | 3.26B | 3.2B | 3.62B | 3.79B | 4.1B | 8.21B |
Effective Tax Rate % | 23.1% | 26% | 34.65% | 17.25% | 18.52% | 17.79% | 19.7% | 20.19% | 20.34% | 39.15% |
Net Income | 15.33B▲ 0% | 9.75B▼ 36.4% | 3.9B▼ 60.0% | 13.03B▲ 234.3% | 14.31B▲ 9.8% | 14.74B▲ 3.0% | 14.65B▼ 0.6% | 14.88B▲ 1.5% | 15.97B▲ 7.4% | 12.72B▲ 0% |
Net Margin % | 23.56% | 14.59% | 5.76% | 18.36% | 18.79% | 18.38% | 17.87% | 17.7% | 18.95% | 14.66% |
Net Income Growth % | 45.85% | -36.38% | -60.03% | 234.28% | 9.82% | 3.05% | -0.6% | 1.54% | 7.36% | -17.94% |
Net Income (Continuing) | 10.19B | 9.86B | 3.97B | 13.1B | 14.35B | 14.79B | 14.74B | 14.97B | 16.07B | 12.76B |
Discontinued Operations | 5.22B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 594M | 590M | 385M | 357M | 276M | 265M | 288M | 272M | 272M | 0 |
EPS (Diluted) | 5.59▲ 0% | 3.67▼ 34.3% | 1.43▼ 61.0% | 4.96▲ 246.9% | 5.50▲ 10.9% | 5.81▲ 5.6% | 5.90▲ 1.5% | 6.02▲ 2.0% | 6.51▲ 8.1% | 5.26▲ 0% |
EPS Growth % | 51.49% | -34.35% | -61.04% | 246.85% | 10.89% | 5.64% | 1.55% | 2.03% | 8.14% | 8.57% |
EPS (Basic) | 5.80 | 3.75 | 1.45 | 5.13 | 5.69 | 6.00 | 6.07 | 6.18 | 6.67 | - |
Diluted Shares Outstanding | 2.74B | 2.66B | 2.54B | 2.63B | 2.6B | 2.54B | 2.48B | 2.47B | 2.45B | 2.42B |
Basic Shares Outstanding | 2.6B | 2.53B | 2.5B | 2.54B | 2.51B | 2.46B | 2.37B | 2.36B | 2.45B | 2.42B |
Dividend Payout Ratio | 47.21% | 74.97% | 192.4% | 59.79% | 57.76% | 59.49% | 61.41% | 62.58% | 61.8% | - |
The Procter & Gamble Company (PG) balance sheet — assets, liabilities & shareholders' equity
| Metric | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 26.49B | 23.32B | 22.47B | 27.99B | 23.09B | 21.65B | 22.65B | 24.71B | 25.39B | 27.99B |
Cash & Short-Term Investments | 15.14B | 11.85B | 10.29B | 16.18B | 10.29B | 7.21B | 8.25B | 9.48B | 9.56B | 12.31B |
Cash Only | 5.57B | 2.57B | 4.24B | 16.18B | 10.29B | 7.21B | 8.25B | 9.48B | 9.56B | 12.31B |
Short-Term Investments | 9.57B | 9.28B | 6.05B | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 4.59B | 4.69B | 4.95B | 4.18B | 4.72B | 5.14B | 5.47B | 6.12B | 6.18B | 6.32B |
Days Sales Outstanding | 25.77 | 25.59 | 26.7 | 21.49 | 22.66 | 23.41 | 24.35 | 26.57 | 26.78 | 26.59 |
Inventory | 4.62B | 4.74B | 5.02B | 5.5B | 5.98B | 6.92B | 7.07B | 7.02B | 7.55B | 7.85B |
Days Inventory Outstanding | 51.71 | 50.23 | 52.67 | 56.93 | 58.85 | 59.95 | 60.38 | 62.69 | 66.95 | 65.82 |
Other Current Assets | 2.14B | 2.05B | 2.22B | 2.13B | 0 | 2.37B | 1.86B | 2.09B | 2.1B | 1.51B |
Total Non-Current Assets | 93.91B | 94.99B | 92.62B | 92.71B | 96.22B | 95.56B | 98.18B | 97.66B | 99.84B | 100.39B |
Property, Plant & Equipment | 19.89B | 20.6B | 21.27B | 20.69B | 21.69B | 21.2B | 21.91B | 22.15B | 23.9B | 24.57B |
Fixed Asset Turnover | 3.27x | 3.24x | 3.18x | 3.43x | 3.51x | 3.78x | 3.74x | 3.79x | 3.53x | 3.57x |
Goodwill | 44.7B | 45.17B | 40.27B | 39.9B | 40.92B | 39.7B | 40.66B | 40.3B | 41.65B | 41.36B |
Intangible Assets | 24.19B | 23.9B | 24.21B | 23.79B | 23.64B | 23.68B | 23.78B | 22.05B | 21.91B | 21.53B |
Long-Term Investments | 0 | 0 | 0 | 0 | 192M | 140M | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 5.13B | 5.31B | 6.86B | 8.33B | 9.77B | 10.84B | 11.83B | 13.16B | 12.38B | 12.93B |
Total Assets | 120.41B▲ 0% | 118.31B▼ 1.7% | 115.09B▼ 2.7% | 120.7B▲ 4.9% | 119.31B▼ 1.2% | 117.21B▼ 1.8% | 120.83B▲ 3.1% | 122.37B▲ 1.3% | 125.23B▲ 2.3% | 128.38B▲ 0% |
Asset Turnover | 0.54x | 0.56x | 0.59x | 0.59x | 0.64x | 0.68x | 0.68x | 0.69x | 0.67x | 0.68x |
Asset Growth % | -5.29% | -1.74% | -2.72% | 4.87% | -1.15% | -1.76% | 3.09% | 1.28% | 2.34% | 11.4% |
Total Current Liabilities | 30.21B | 28.24B | 30.01B | 32.98B | 33.13B | 33.08B | 35.76B | 33.63B | 36.06B | 38.23B |
Accounts Payable | 9.63B | 10.34B | 11.26B | 12.07B | 13.72B | 14.88B | 14.6B | 15.36B | 15.23B | 15.03B |
Days Payables Outstanding | 107.72 | 109.65 | 118.21 | 124.99 | 134.95 | 128.85 | 124.61 | 137.29 | 135.02 | 129.31 |
Short-Term Debt | 13.55B | 10.42B | 9.7B | 11.18B | 8.89B | 8.64B | 10.23B | 7.19B | 9.51B | 13.17B |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 3.6B | 3.97B | 4.41B | 5.26B | 5.53B | 4.88B | 5.75B | 5.33B | 5.74B | 25.06B |
Current Ratio | 0.88x | 0.83x | 0.75x | 0.85x | 0.70x | 0.65x | 0.63x | 0.73x | 0.70x | 0.73x |
Quick Ratio | 0.72x | 0.66x | 0.58x | 0.68x | 0.52x | 0.45x | 0.44x | 0.53x | 0.49x | 0.53x |
Cash Conversion Cycle | -30.23 | -33.83 | -38.84 | -46.57 | -53.45 | -45.49 | -39.88 | -48.02 | -41.28 | -36.9 |
Total Non-Current Liabilities | 34.42B | 37.19B | 37.51B | 40.85B | 39.52B | 37.27B | 38.01B | 38.19B | 36.89B | 35.41B |
Long-Term Debt | 18.04B | 20.86B | 20.39B | 23.54B | 23.1B | 22.85B | 24.38B | 25.27B | 25B | 23.85B |
Capital Lease Obligations | 38M | 85M | 0 | 652M | 631M | 595M | 595M | 666M | 701M | 701M |
Deferred Tax Liabilities | 8.13B | 6.16B | 6.9B | 6.2B | 6.15B | 6.81B | 6.48B | 6.52B | 5.77B | 23.69B |
Other Non-Current Liabilities | 8.22B | 10.08B | 10.21B | 10.46B | 9.64B | 7.02B | 6.56B | 5.73B | 5.42B | 5.51B |
Total Liabilities | 64.63B | 65.43B | 67.52B | 73.82B | 72.65B | 70.35B | 73.76B | 71.81B | 72.95B | 73.65B |
Total Debt | 31.64B | 31.39B | 30.1B | 35.61B | 32.84B | 32.29B | 35.42B | 33.37B | 35.46B | 37.03B |
Net Debt | 26.07B | 28.82B | 25.86B | 19.43B | 22.55B | 25.08B | 27.18B | 23.89B | 25.91B | 24.72B |
Debt / Equity | 0.57x | 0.59x | 0.63x | 0.76x | 0.70x | 0.69x | 0.75x | 0.66x | 0.68x | 0.68x |
Debt / EBITDA | 1.91x | 1.94x | 3.62x | 1.90x | 1.58x | 1.57x | 1.70x | 1.56x | 1.52x | 1.69x |
Net Debt / EBITDA | 1.57x | 1.78x | 3.11x | 1.04x | 1.09x | 1.22x | 1.30x | 1.11x | 1.11x | 1.13x |
Interest Coverage | 29.51x | 27.34x | 12.92x | 35.05x | 36.09x | 41.99x | 25.28x | 21.28x | 23.23x | -487.21x |
Total Equity | 55.78B▲ 0% | 52.88B▼ 5.2% | 47.58B▼ 10.0% | 46.88B▼ 1.5% | 46.65B▼ 0.5% | 46.85B▲ 0.4% | 47.06B▲ 0.5% | 50.56B▲ 7.4% | 52.28B▲ 3.4% | 54.73B▲ 0% |
Equity Growth % | -3.8% | -5.19% | -10.03% | -1.47% | -0.48% | 0.43% | 0.45% | 7.42% | 3.41% | 13.92% |
Book Value per Share | 20.35 | 19.91 | 18.74 | 17.85 | 17.94 | 18.45 | 18.95 | 20.45 | 21.30 | 22.65 |
Total Shareholders' Equity | 55.18B | 52.29B | 47.19B | 46.52B | 46.38B | 46.59B | 46.78B | 50.29B | 52.01B | 54.73B |
Common Stock | 4.01B | 4.01B | 4.01B | 4.01B | 4.01B | 4.01B | 4.01B | 4.01B | 4.01B | 0 |
Retained Earnings | 96.12B | 98.64B | 94.92B | 100.24B | 106.37B | 112.43B | 118.17B | 123.81B | 129.97B | 135.42B |
Treasury Stock | -93.72B | -99.22B | -100.41B | -105.57B | -114.97B | -123.38B | -129.74B | -133.38B | -138.7B | 0 |
Accumulated OCI | -14.63B | -14.75B | -14.94B | -16.16B | -13.74B | -12.19B | -12.22B | -11.9B | -12.14B | -12.3B |
Minority Interest | 594M | 590M | 385M | 357M | 276M | 265M | 288M | 272M | 272M | 0 |
The Procter & Gamble Company (PG) cash flow — operating, investing & free cash flow history
| Metric | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 12.75B | 14.87B | 15.24B | 17.4B | 18.37B | 16.72B | 16.85B | 19.85B | 17.82B | 19.41B |
Operating CF Margin % | 19.6% | 22.25% | 22.52% | 24.53% | 24.13% | 20.86% | 20.54% | 23.62% | 21.14% | - |
Operating CF Growth % | -17.38% | 16.58% | 2.52% | 14.18% | 5.56% | -8.97% | 0.75% | 17.79% | -10.22% | 24.57% |
Net Income | 15.33B | 9.86B | 3.97B | 13.1B | 14.35B | 14.79B | 14.74B | 14.88B | 16.07B | 12.72B |
Depreciation & Amortization | 2.82B | 2.83B | 2.82B | 3.01B | 2.73B | 2.81B | 2.71B | 2.9B | 2.85B | 3.07B |
Stock-Based Compensation | 366M | 395M | 515M | 558M | 540M | 528M | 545M | 562M | 476M | 506M |
Deferred Taxes | -601M | -1.84B | -411M | -596M | -258M | -402M | -453M | -244M | 149M | 144M |
Other Non-Cash Items | -4.71B | 601M | 7.98B | 115M | 631M | 144M | 524M | 2.19B | 755M | -3.46B |
Working Capital Changes | -443M | 3.02B | 368M | 1.21B | 371M | -1.15B | -1.22B | -436M | -2.47B | 2.46B |
Change in Receivables | -322M | -177M | -276M | 634M | -342M | -694M | -307M | -766M | 45M | -62M |
Change in Inventory | 71M | -188M | -239M | -637M | -309M | -1.25B | -119M | -70M | -324M | -261M |
Change in Payables | -149M | 1.39B | 1.86B | 1.92B | 1.39B | 1.43B | 313M | 1.81B | -542M | 1.32B |
Cash from Investing | -6.68B | -3.51B | -3.49B | 3.04B | -2.83B | -4.42B | -3.5B | -3.5B | -3.82B | -4.49B |
Capital Expenditures | -3.38B | -3.72B | -3.35B | -3.07B | -2.79B | -3.16B | -3.06B | -3.32B | -3.77B | -4.38B |
CapEx % of Revenue | 5.2% | 5.56% | 4.95% | 4.33% | 3.66% | 3.94% | 3.73% | 3.95% | 4.48% | 5.05% |
Acquisitions | -491M | -109M | -3.94B | -58M | -34M | -1.38B | -765M | -21M | -11M | -85M |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 571M | 269M | 394M | 30M | 42M | 110M | 327M | -161M | -34M | -24M |
Cash from Financing | -8.57B | -14.38B | -9.99B | -8.37B | -21.53B | -14.88B | -12.15B | -14.86B | -14.04B | -11.77B |
Debt Issued (Net) | 1.4B | -1.24B | -817M | 4.85B | -3.9B | 1.89B | 2.94B | -2.44B | 630M | 1.62B |
Equity Issued (Net) | -5.2B | -7B | -5B | -7.41B | -11.01B | -10B | -7.35B | -5.01B | -4.79B | -4.23B |
Dividends Paid | -7.24B | -7.31B | -7.5B | -7.79B | -8.26B | -8.77B | -9B | -9.31B | -9.87B | -10.18B |
Share Repurchases | -5.2B | -7B | -5B | -7.41B | -11.01B | -10B | -7.35B | -5.01B | -6.5B | -4.85B |
Other Financing | 2.47B | 1.18B | 3.32B | 1.98B | 1.64B | 2B | 1.27B | 1.91B | -1M | 1.02B |
Net Change in Cash | -1.53B▲ 0% | -3B▼ 95.7% | 1.67B▲ 155.7% | 11.94B▲ 615.1% | -5.89B▼ 149.3% | -3.07B▲ 47.8% | 1.03B▲ 133.6% | 1.24B▲ 19.8% | 74M▼ 94.0% | 3.19B▲ 0% |
Free Cash Flow | 9.37B▲ 0% | 11.15B▲ 19.0% | 11.89B▲ 6.7% | 14.33B▲ 20.5% | 15.58B▲ 8.8% | 13.57B▼ 12.9% | 13.79B▲ 1.6% | 16.52B▲ 19.9% | 14.04B▼ 15.0% | 15.03B▲ 0% |
FCF Margin % | 14.4% | 16.68% | 17.57% | 20.2% | 20.47% | 16.92% | 16.81% | 19.66% | 16.66% | 17.33% |
FCF Growth % | -22.7% | 19.01% | 6.68% | 20.47% | 8.75% | -12.94% | 1.61% | 19.86% | -15.01% | 0.02% |
FCF per Share | 3.42 | 4.20 | 4.68 | 5.46 | 5.99 | 5.34 | 5.55 | 6.68 | 5.72 | 6.22 |
FCF Conversion (FCF/Net Income) | 0.83x | 1.52x | 3.91x | 1.34x | 1.28x | 1.13x | 1.15x | 1.33x | 1.12x | 1.18x |
Interest Paid | 518M | 529M | 497M | 434M | 531M | 451M | 721M | 878M | 896M | 0 |
Taxes Paid | 3.71B | 2.83B | 3.06B | 3.55B | 3.82B | 3.82B | 4.28B | 4.36B | 4.55B | 0 |
The Procter & Gamble Company (PG) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 26.94% | 17.95% | 7.76% | 27.58% | 30.59% | 31.53% | 31.2% | 30.48% | 31.07% | 23.78% |
Return on Invested Capital (ROIC) | 12.64% | 12.26% | 5.3% | 16.86% | 19.91% | 18.93% | 18.61% | 18.71% | 20.1% | 19.19% |
Gross Margin | 49.83% | 48.48% | 48.63% | 50.32% | 51.25% | 47.43% | 47.86% | 51.39% | 51.16% | 50.33% |
Net Margin | 23.56% | 14.59% | 5.76% | 18.36% | 18.79% | 18.38% | 17.87% | 17.7% | 18.95% | 14.66% |
Debt / Equity | 0.57x | 0.59x | 0.63x | 0.76x | 0.70x | 0.69x | 0.75x | 0.66x | 0.68x | 0.68x |
Interest Coverage | 29.51x | 27.34x | 12.92x | 35.05x | 36.09x | 41.99x | 25.28x | 21.28x | 23.23x | -487.21x |
FCF Conversion | 0.83x | 1.52x | 3.91x | 1.34x | 1.28x | 1.13x | 1.15x | 1.33x | 1.12x | 1.18x |
Revenue Growth | -0.37% | 2.73% | 1.27% | 4.83% | 7.28% | 5.35% | 2.27% | 2.48% | 0.29% | 3.33% |
The Procter & Gamble Company (PG) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 24, 2026·SEC
Apr 24, 2026·SEC
Apr 14, 2026·SEC
Aug 4, 2025·SEC
The Procter & Gamble Company (PG) stock FAQ — growth, dividends, profitability & financials explained
The Procter & Gamble Company (PG) reported $86.72B in revenue for fiscal year 2025. This represents a 146% increase from $35.28B in 1996.
The Procter & Gamble Company (PG) grew revenue by 0.3% over the past year. Growth has been modest.
Yes, The Procter & Gamble Company (PG) is profitable, generating $12.72B in net income for fiscal year 2025 (19.0% net margin).
Yes, The Procter & Gamble Company (PG) pays a dividend with a yield of 2.67%. This makes it attractive for income-focused investors.
The Procter & Gamble Company (PG) has a return on equity (ROE) of 31.1%. This is excellent, indicating efficient use of shareholder capital.
The Procter & Gamble Company (PG) generated $15.03B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.